Author:
Bennett Martin R,Schwartz Stephen M
Reference84 articles.
1. Wang, A, Creasy, A, Lardner, M, Lin, L, Strickler, J, Van Arsdell, J, Yamamoto, R and Mark, D. Molecular cloning of the complementary DNA for human tumor necrosis factor. Science. 1985; 228:149–154.
2. Holt, J T, Redner, R L and Nienhuis, A W. An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. Mol Cell Biol.1988; 8:963–973.
3. Bennett, M R, Anglin, S, McEwan, J R, Jagoe, R, Newby, A C and Evan, G I. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. J Clin Invest. 1994; 93:820–828.
4. Saison, B T, Tocqu’e, B, Rey, I, Chassignol, M, Thuong, N T and H’elene, C. Short modified antisense oligonucleotides directed against Ha-ras point mutation induce selective cleavage of the mRNA and inhibit T24 cells proliferation. Embo J.1991; 10:1111–1118.
5. Gao, W Y, Storm, C, Egan, W and Cheng, Y C.Cellular pharmacology of phosphorothioate homooligodeoxynucleotides in human cells. Mol Pharmacol.1993; 43:45–50.